Baeuerle Patrick
SEC CIK 1362054 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | See Remarks | 76.0K | — | $610.0K | 6 | 2021-08-10 | 2023-02-17 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Baeuerle Patrick made no open-market trades at CGEM in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-17 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | CSO | A - Grant | $0.00 | +38.5K | 76.0K | +103% | $0 |
| D | 2022-02-15 | 2022-02-11 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | See Remarks | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
| D | 2021-09-09 | 2021-09-08 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | See Remarks | M - OptEx | $4.30 | +11.0K | 11.0K | New | +$47.3K |
| D | 2021-09-09 | 2021-09-08 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | See Remarks | S - Sale+OE | $28.45 | -11.0K | 0 | -100% | -$312.9K |
| D | 2021-08-26 | 2021-08-10 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | See Remarks | S - Sale+OE | $27.00 | -11.0K | 0 | -100% | -$297.0K |
| D | 2021-08-26 | 2021-08-10 | CGEM | Cullinan Therapeutics, Inc. | Baeuerle Patrick | See Remarks | M - OptEx | $4.30 | +11.0K | 11.0K | New | +$47.3K |
Purchase Sale Sale after option exercise All abbreviations